Tuesday 11 February |
TUI |
Ormonde Mining (re disposal of 30% stake in Barruecopardo tungsten mine) |
Cineworld Group (re proposed acquisition of Cineplex) |
BMO Capital & Income Investment Trust |
Keystone Investment Trust |
Wednesday 12 February |
UK Oil & Gas (re cash and shares in company) |
Oxford Metrics |
RWS Holdings |
Thursday 13 February |
GCP Infrastructure Investments |
Watkin Jones |
Tritax Eurobox |
Paragon Banking Group |
Friday 14 February |
no events scheduled |
Monday 17 February |
ValiRx (re capital reorganisation) |
Toople (re to approve DMS Holdings acquisition) |
Ultimate Sports (re name change to Catena Group) |
Copyright 2020 Alliance News Limited. All Rights Reserved. |
ValiRx secures 'substantial amendment' to VAL201 clinical trials
(Sharecast News) - Clinical stage biotechnology company ValiRx updated the market on 'VAL201' on Thursday, confirming that, based on clinical results, a "substantial amendment" to the clinical trial protocol had received regulatory approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) and the research ethics committee.
Read more